Advancing AAV: Novel Synthesis and Sequencing Solutions for Gene Therapy Research

Presented By: Andrea O'Hara, PhD

Speaker Biography: Dr. Andrea O'Hara earned her Ph.D. in genetics and molecular biology from the University of North Carolina at Chapel Hill, and has more than 11 years of experience in next generation sequencing (NGS). She is currently a strategic technical specialist at GENEWIZ within the NGS team.

Webinar: Advancing AAV: Novel Synthesis and Sequencing Solutions for Gene Therapy Research

Webinar Abstract: Interest in cell and gene therapy-based disease prevention and treatment has increased rapidly over the last few decades, however there are still many hurdles to overcome and further progress to be made in the field. In this presentation, Dr. Andrea O’Hara will discuss GENEWIZ’s innovative gene therapy solutions across the clinical development pipeline, highlighting adeno-associated virus (AAV) plasmid DNA sequencing (RUO/GLP), preparation, and synthesis solutions for recombinant AAV (rAAV) production, which includes confirmation, maintenance, and correction of inverted terminal repeat (ITR) regions.

Earn PACE Credits:

Labroots on Social:
SnapChat: labroots_inc